Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
Clinic materno infaltil San Luis, Bucaramanga, Santander, Colombia
Jeju National University Hospital, Jeju, Korea, Republic of
Mount Sinai Hospital, Toronto, Ontario, Canada
Faculty of Medicine, Assiut, Egypt
West China Hospital affiliated to Sichuan University, Chengdu, Sichuan, China
The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Shenzhen People's Hospital, Shenzhen, Guangdong, China
Tunis maternity and neonatology center, minisetry of public health, Tunis, Tunisia
Seoul National University Hospital, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.